Alberto J. Espay, MD, MSc, discusses a new biological definition of Parkinson's disease that is based on pathology identified through spinal fluid testing. The test uses the principles of ...

To the clinical eye, Parkinson’s Disease is defined by the degradation of dopamine-producing neurons in the substantia nigra. But to the patient, the definition is far more visceral: it is the ...

The International Society for Stem Cell Research (ISSCR) today announced the launch of Stem Cell Medicine: Parkinson's Disease, a new continuing education course designed to equip clinicians with an ...

This week, Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about research underway to explore the use of stem cell therapy ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, ...

December 1, 2010 — A 28-member expert panel of the American Academy of Neurology (AAN) has developed and published a set of 10 quality measures for the care of patients with Parkinson's disease (PD).

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression. According to ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to ...